Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/27/2012WO2012174674A1 Light-sensitive chimeric gpcr protein
12/27/2012WO2012174666A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012WO2012143543A3 Plants resistant to insect pests
12/27/2012WO2012143513A3 Yeast cell capable of converting sugars including arabinose and xylose
12/27/2012WO2012142604A3 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9
12/27/2012WO2012142245A3 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
12/27/2012WO2012134921A3 Plant regulatory elements and uses thereof
12/27/2012WO2012134262A3 A method for extracting protein from pectin rich plant material
12/27/2012WO2012118972A3 Process of preparing guanylate cyclase c agonists
12/27/2012WO2012085936A4 Recombinant respiratory syncytial virus plasmids and vaccines
12/27/2012WO2012079088A3 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
12/27/2012WO2012075243A3 Methods and compositions for targeting sites of neovascular growth
12/27/2012WO2012075104A3 Novel non-primate hepacivirus
12/27/2012WO2012050919A3 Chimeric spider silk and uses thereof
12/27/2012WO2012012531A9 Compositions and methods featuring il-6 and il-21 antagonists
12/27/2012US20120331581 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/27/2012US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
12/27/2012US20120330838 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
12/27/2012US20120330001 Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
12/27/2012US20120329993 Soy whey protein compositions and methods for recovering same
12/27/2012US20120329992 Spider silk proteins and methods for producing spider silk proteins
12/27/2012US20120329991 Agent for preventing muscle atrophy
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329733 Methods and products related to metabolic interactions in disease
12/27/2012US20120329725 Chimeric Peptides for the Regulation of GTPases
12/27/2012US20120329721 Means for preventing and treating cellular death and their biological applications
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof
12/27/2012US20120329711 Glp-1 receptor agonist compounds with a modified n-terminus
12/27/2012US20120329709 Production of glycoproteins
12/27/2012US20120329708 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329707 Glucagon/glp-1 receptor co-agonists
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329703 Potent and Selective Mediators of Cholesterol Efflux
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329670 Epitope testing using soluble hla
12/27/2012US20120329162 Genetically encoded fluorescent coumarin amino acids
12/27/2012US20120329129 Magnetic nanoparticle with biocompatibility
12/27/2012US20120329114 Xylose utilizing zymomonas mobilis with improved ethanol production in biomass hydrolysate medium
12/27/2012US20120329080 Anti-hla assay and methods
12/27/2012US20120329078 Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker
12/27/2012US20120329065 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329057 Beef-specific age determination marker containing the p21 protein
12/27/2012US20120329056 Methods of evaluating relapse risk of acute myeloid leukemia using nucleic acids or fragments encoding flt3 kinase
12/27/2012US20120328735 Process for preparing casein-derived peptides by fermentation of lactic acid bacteria
12/27/2012US20120328699 Method and composition for treatment of skeletal dysplasias
12/27/2012US20120328684 Citrobacter freundii antibacterial agents and their use
12/27/2012US20120328659 Treatment of streptococcal infections
12/27/2012US20120328658 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328657 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328651 Chimpanzee adenovirus vaccine carriers
12/27/2012US20120328650 Modified vaccinia ankara virus variant
12/27/2012US20120328646 Globo H and Related Anti-Cancer Vaccines with Novel Glycolipid Adjuvants
12/27/2012US20120328641 Conformationally stabilized hiv envelope immunogens
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328636 Kdr peptides and vaccines comprising the same
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328622 Novel compounds
12/27/2012US20120328621 Immunogens, compositons and uses thereof, method for preparing same
12/27/2012US20120328620 Epidermalgrowth factor receptor mutations
12/27/2012US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328575 Modified Oncolytic Viruses
12/27/2012US20120328568 Compositions and uses of lectins
12/27/2012US20120328562 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients
12/27/2012US20120328560 Method for obtaining biologically active recombinant human g-csf
12/27/2012US20120328534 Enzymatic peracid generation for use in oral care products
12/27/2012US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012US20120328513 Compositions against cancer antigen liv-1 and uses thereof
12/27/2012US20120328512 Fibrin-Binding Peptides and Conjugates Thereof
12/27/2012DE102004031579B4 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins, these nucleic acid molecule comprising, vector, host cell recognition molecule directed against these, these containing pharmaceutical composition containing them and their use kit
12/27/2012CA2840458A1 Light-sensitive chimeric gpcr protein
12/27/2012CA2840113A1 An il-15 and il-15r.alpha. sushi domain based immunocytokines
12/27/2012CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
12/27/2012CA2839887A1 Recombinant yeast expressing agt1
12/27/2012CA2839867A1 Glucagon/glp-1 receptor co-agonists
12/27/2012CA2839834A1 Binding domains directed against gpcr:g protein complexes and uses derived thereof
12/27/2012CA2839777A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012CA2839711A1 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
12/27/2012CA2839634A1 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
12/27/2012CA2839563A1 Anti-alpha synuclein binding molecules
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839024A1 Modified antibiotic peptides having variable systemic release
12/27/2012CA2838621A1 Plants having enhanced yield-related traits and a method for making the same
12/27/2012CA2837658A1 Pcsk9-binding polypeptides and methods of use
12/27/2012CA2835772A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
12/27/2012CA2834618A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
12/26/2012EP2538223A2 Biochemical markers for CVD risk assessment
12/26/2012EP2538222A2 Biochemical markers for CVD risk assessment
12/26/2012EP2538221A2 Biochemical markers for CVD risk assessment
12/26/2012EP2538218A2 Biochemical markers for CVD risk assessment
12/26/2012EP2537940A2 Plants having increased yield-related traits and a method for making the same
12/26/2012EP2537933A1 An IL-15 and IL-15Ralpha sushi domain based immunocytokines
12/26/2012EP2537932A1 Compositions for and methods of identifying antigens
12/26/2012EP2537929A1 Plant component regulation factor, and use thereof
12/26/2012EP2537863A1 Chemically modified water-soluble elastin, mixed gels of chemically modified water-soluble elastin with collagen and method for producing same
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 2916